EVT — Evotec SE Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual cashflow statement for Evotec SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	216	-176	-83.9	-196	-104
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	-165	211	50.2	105	40.9
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-0.576	86.8	-22.8	7.88	-46
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	122	206	36.4	18.2	-9.18
Capital Expenditures	-119	-181	-216	-132	-82.6
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-125	-231	203	61	254
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-244	-413	-13.3	-71.2	172
Financing Cash Flow Items	—	-5.73	-12.9	-9.72	-6.89
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	398	-58.1	72	-161	-37.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	277	-284	95.8	-205	112